Cop27: a chance for change – or more of the same?

Loading player...
On Sunday, world leaders, negotiators and industry representatives will begin to arrive in Sharm el-Sheik in Egypt for Cop27, the UN’s climate change conference. A UN report set the stage for talks last week, stating that there is “no credible pathway to 1.5C in place” and that progress on limiting global temperature rises has been “woefully inadequate”. So will governments take the opportunity to press ahead with their promises or could the conference live up to accusations of greenwashing? In the first of five special episodes covering Cop27, Madeleine Finlay hears from Guardian Australia’s climate and environment editor Adam Morton about what’s happened since Cop26, our current path to catastrophic heating and what’s likely to be on the agenda over the next two weeks. Help support our independent journalism at theguardian.com/sciencepod
3 Nov 2022 English United Kingdom Science · Nature

Other recent episodes

Can a name change transform PCOS outcomes for women?

After more than a decade of global consultation, polycystic ovary syndrome – which affects as many as one in eight women – has been renamed. The condition is caused by high levels of androgens, which can lead to symptoms such as excess hair, weight gain and irregular periods. To understand…
21 May 16 min

Ebola outbreak: what do we know and can it be contained?

An outbreak of Ebola has emerged in the Democratic Republic of Congo and Uganda, which has led to nearly 400 confirmed cases and more than 100 deaths. To find out how the outbreak might have begun, what authorities can do to contain it and why this outbreak is causing particular…
18 May 13 min

Hantavirus update, Pentagon’s UFO files, can art slow biological ageing?

Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eyecatching stories from the week, including an update on hantavirus. Also on the agenda is the Pentagon’s release of a tranche of never before seen documents relating to UFOs, and a study looking at the link…
14 May 21 min

Trump is backing psychedelic research: here’s why

Last month President Trump signed an executive order designed to fast track both research and access to psychedelic drugs as treatments for mental health illnesses. The most prominent in the order was ibogaine, a drug derived from the root bark of a West African shrub, that has shown some promise…
12 May 17 min